{"id":"NCT02101359","sponsor":"Laboratoires Thea","briefTitle":"Efficacy and Safety Assessment of Intracameral Injection of T2380 in Cataract Surgery","officialTitle":"Efficacy and Safety Assessment of Intracameral Injection of T2380 in Cataract Surgery Versus Reference Group (Topical Mydriatics and Anaesthetic)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-06","primaryCompletion":"2013-01","completion":"2013-05","firstPosted":"2014-04-02","resultsPosted":"2014-09-25","lastUpdate":"2014-11-14"},"enrollment":609,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Cataract"],"interventions":[{"type":"DRUG","name":"T2380","otherNames":[]},{"type":"DRUG","name":"Mydriatics","otherNames":["Tropicamide, Phenylpehrine"]},{"type":"DRUG","name":"Tetracaine","otherNames":["Tetracaine 1%"]}],"arms":[{"label":"T2380","type":"EXPERIMENTAL"},{"label":"Mydriatics and anesthetic","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to determine the efficacy and safety assessment of T2380 for mydriasis and anaesthesia in phacoemulsification cataract surgery versus reference group (topical mydriatics and anaesthetic) 2X246 patients.","primaryOutcome":{"measure":"The Primary Efficacy Variable is Response Based on the Realisation of the Capsulorhexis Without Use of Any Additive Mydriatic Treatment.","timeFrame":"Day 0","effectByArm":[{"arm":"T2380","deltaMin":98.9,"sd":null},{"arm":"Reference Group","deltaMin":94.7,"sd":null}],"pValues":[]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":1,"countries":["France"]},"refs":{"pmids":["32126990","26531052"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":295},"commonTop":[]}}